These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1388997)

  • 1. Surfactant replacement therapy in newborns with hyaline membrane disease.
    Grobman DW; Foley MM
    Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant replacement therapy. Innovative care for the premature infant.
    Miller EP; Armstrong CL
    J Obstet Gynecol Neonatal Nurs; 1990; 19(1):14-7. PubMed ID: 2299437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP; Zhang XL; Ma WX; Sun YP; Li XH; Yu JH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):248. PubMed ID: 17448287
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.
    CMAJ; 1992 Apr; 146(8):1309-12. PubMed ID: 1555161
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA; Hutchins GM
    Am J Perinatol; 1998; 15(9):539-44. PubMed ID: 9890252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Administration of surfactant in hyaline membrane disease].
    Valls i Soler A
    An Esp Pediatr; 1987 Sep; 27(3):147-51. PubMed ID: 3322119
    [No Abstract]   [Full Text] [Related]  

  • 10. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract]   [Full Text] [Related]  

  • 11. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA; Metcalfe IL; Duffty P; Possmayer F; Bryan MH; Enhorning G
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D; Shimada S
    Clin Perinatol; 1987 Dec; 14(4):991-1015. PubMed ID: 3322633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O; Lapillonne A; Madinier-Chappat N; Miguet D; Salle BL
    Cah Anesthesiol; 1994; 42(3):325-8. PubMed ID: 7812856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of surfactant replacement therapy in a developing country.
    al Umran K; Yaseen H
    J Trop Pediatr; 1997 Jun; 43(3):167-9. PubMed ID: 9231638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary surfactant and its clinical application.
    Jin HZ
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract]   [Full Text] [Related]  

  • 17. The selection of infants for surfactant replacement therapy under conditions of limited financial resources.
    Ballot DE; Rothberg AD; Davies VA
    S Afr Med J; 1995 Jul; 85(7):640-3. PubMed ID: 7482079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The late administration of surfactant.
    Ballot DE; Rothberg AD; Davies VA
    S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness and cost of exogenous pulmonary surfactant replacement therapy.
    Smith J; Pieper C; Gie RP
    S Afr Med J; 1995 Nov; 85(11):1192, 1195-6. PubMed ID: 8597017
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams.
    Kresch MJ; Clive JM
    J Perinatol; 1998; 18(4):276-83. PubMed ID: 9730197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.